Business Wire

Cloud Service Provider Bulutistan Selects Inspur Information to Upgrade Its Cloud Infrastructure

Share

Inspur Information, a leading IT infrastructure solutions provider, today announced it was selected by Bulutistan, the leading cloud service provider in Turkey and a top 5 provider in the EMEA region, to upgrade the company’s cloud infrastructure. Bulutistan faces rapid growth in its public cloud services that cannot be met by traditional cloud computing architecture. Inspur Information’s hyper-converged solution based on Inspur’s NF5280M5 server provides the extreme scalability Bulutistan requires in addition to a 30% reduction in operational costs.

The three-tier architecture of traditional data centers (computing, storage, and network) is stable and reliable, but it is difficult to expand and requires complex equipment and that is time consuming and difficult to manage. It is not suitable for the next-generation data center cloudification that Bulutistan requires. Instead, the company needed a pooled IT infrastructure platform with maximum capacity and scalability that is also efficient, easy to adjust and manage, and highly stable.

Understanding Bulutistan’s requirements for extreme scalability, flexibility, and stability, Inspur went through an extensive testing process and identified Nutanix's distributed storage software as the most effective way to integrate computing and storage. The Inspur hyper-converged solution and NF5280M5 server paired with Nutanix software would allow Bulutistan to upgrade to a customized cloud server platform with full-stack management analysis that is flexible and allows for unlimited expansion as an on-premises integrated solution. This logically simplified architecture is the key to why Bulutistan selected Inspur to upgrade its cloud infrastructure.

The Inspur one-click database management solution supports multiple file storage services and greatly simplifies system management. The hyper-converged architecture with distributed single-node management achieves excellent performance with high stability and advanced recovery capabilities. The solution can flexibly allocate computing resources across clusters and units without reconfiguring the physical network or external storage. Computing virtualization is achieved through VMware, and network virtualization is achieved through NFV to provide simple and intuitive configuration management tools for allocating resources. Server computing and storage resources can be adjusted according to actual needs for true on-demand and dynamic resource allocation.

The system greatly simplifies management complexity and improves operation and maintenance efficiency, resulting in a 30% reduction in costs. Modular construction with on-demand linear and rapid expansion reduces deployment times to 1/6th of what is typically expected. A highly scalable network interface is provided, further simplifying deployment and reducing operating costs.

This integration reduces operating costs while providing the same data reliability and availability of traditional architectures. Inspur Information offers a complete solution for a virtualization platform, including high-availability storage design, data security, and management. The hyper-converged solution developed for Bulutistan integrates a variety of analysis technologies, and creates a complete pooled IT platform by combining hyper-convergence, VMware virtualization, NFV, and storage.

About Inspur Information

Inspur Information is a leading provider of data center infrastructure, cloud computing, and AI solutions, and is a top two server manufacturer worldwide. Through engineering and innovation, Inspur Information delivers cutting-edge computing hardware design and extensive product offerings to address important technology segments such as open computing, cloud data centers, AI, and deep learning. Performance-optimized and purpose-built, our world-class solutions empower customers to tackle real-world challenges and custom workloads. To learn more, please go to https://www.inspur.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Fiona Liu
Inspur Information
liuxuan01@inspur.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 15:00:00 EEST | Press release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall deep and durable responses across the frontline CLL patient spectrum, including patients with high-risk mutational status. The best undetectable minimal residual disease (uMRD) rate in peripheral blood at a sensitivity level 10-4 was 59%. These efficacy responses observed in Arm D, despite the high proportion of high-risk patients enrolled, are in

You Up? Grindr’s “Right Now” Goes Global30.5.2025 16:00:00 EEST | Press release

Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded people without wasting time on mismatched expectations. The response to our initial March launc

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 15:00:00 EEST | Press release

Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative financing approaches to manage the costs of treatment and care. “Despite CAR T-cell therapy being available in the United States for nearly seven years in large B-cell lymphoma, only approximately two out of 10 eligible patients with some advanced blood cancers ever receive CAR T-cell therapy,” said Miguel Perale

Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 12:17:00 EEST | Press release

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha

FDA Grants De Novo Clearance for Reflow Medical's Spur ® Peripheral Retrievable Stent System30.5.2025 07:08:00 EEST | Press release

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye